Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2025-01-21 Sale |
2025-01-23 5:06 pm |
Acumen Pharmaceuticals Inc. | ABOS | Siemers Eric Chief Medical Officer |
3,219 | $1.59 | $5,118 | 170,298 (Direct) |
View |
2025-01-03 Sale |
2025-01-07 7:48 pm |
Acumen Pharmaceuticals Inc. | ABOS | Siemers Eric Chief Medical Officer |
10,859 | $1.8461 | $20,047 | 273,817 (Direct) |
View |
2024-01-18 Sale |
2024-01-19 7:05 pm |
Acumen Pharmaceuticals Inc. | ABOS | Siemers Eric Chief Medical Officer |
3,124 | $3.7144 | $11,604 | 117,576 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-01-06 Option Award |
2025-01-07 7:48 pm |
N/A 2035-01-06 |
Acumen Pharmaceuticals Inc. | ABOS | Siemers Eric Chief Medical Officer |
167,100 | $0 | 273,817 (Direct) |
View |
2024-01-02 Option Award |
2024-01-04 4:21 pm |
N/A 2034-01-01 |
Acumen Pharmaceuticals Inc. | ABOS | Siemers Eric Chief Medical Officer |
235,000 | $0 | 261,700 (Direct) |
View |
2023-01-17 Option Award |
2023-01-18 4:23 pm |
N/A 2033-01-16 |
Acumen Pharmaceuticals Inc. | ABOS | Siemers Eric Chief Medical Officer |
146,900 | $0 | 146,900 (Direct) |
View |
2022-01-19 Option Award |
2022-01-21 4:21 pm |
N/A 2032-01-19 |
Acumen Pharmaceuticals Inc. | ABOS | Siemers Eric Chief Medical Officer |
90,000 | $0 | 90,000 (Direct) |
View |
Ownership |
2021-06-30 6:55 pm |
N/A 2029-03-01 |
Acumen Pharmaceuticals Inc. | ABOS | Siemers Eric Chief Medical Officer |
0 | $0 | 497,789 (Direct) |
View |